SF3B1-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation

MLA

Pozzo, F., et al. SF3B1-Mutated Chronic Lymphocytic Leukemia Shows Evidence of NOTCH1 Pathway Activation Including CD20 Downregulation. Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....c088e58c301c42ceb725df43f870fc5c&authtype=sso&custid=ns315887.

APA

Pozzo, F., Bittolo, T., Tissino, E., Vit, F., Vendramini, E., Laurenti, L., D’Arena, G., Olivieri, J., Pozzato, G., Zaja, F., Chiarenza, A., Di Raimondo, F., Zucchetto, A., Bomben, R., Rossi, F., Del Poeta, G., Dal Bo, M., & Gattei, V. (2020). SF3B1-mutated chronic lymphocytic leukemia shows evidence of NOTCH1 pathway activation including CD20 downregulation.

Chicago

Pozzo, F, T Bittolo, E Tissino, F Vit, E Vendramini, L Laurenti, G D’Arena, et al. 2020. “SF3B1-Mutated Chronic Lymphocytic Leukemia Shows Evidence of NOTCH1 Pathway Activation Including CD20 Downregulation,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid.dedup....c088e58c301c42ceb725df43f870fc5c&authtype=sso&custid=ns315887.